1 |
Bayetto K, Logan RM. Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management. Aust Dent J 2010;55 Suppl 1:39-47.
DOI
|
2 |
Park YS, Gauna AE, Cha S. Mouse models of primary Sjogren's syndrome. Curr Pharm Des 2015;21:2350-2364.
DOI
|
3 |
Fox RI. Sjogren's syndrome. Lancet 2005;366:321-331.
DOI
|
4 |
Nguyen CQ, Peck AB. Unraveling the pathophysiology of Sjogren syndrome-associated dry eye disease. Ocul Surf 2009;7:11-27.
DOI
|
5 |
Li X, Golden J, Faustman DL. Faulty major histocompatibility complex class II I-E expression is associated with autoimmunity in diverse strains of mice. Autoantibodies, insulitis, and sialadenitis. Diabetes 1993;42:1166-1172.
DOI
|
6 |
Wicker LS, Todd JA, Prins JB, Podolin PL, Renjilian RJ, Peterson LB. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd10, protect nonobese diabetic mice from diabetes. J Exp Med 1994;180:1705-1713.
DOI
|
7 |
Killedar SJ, Eckenrode SE, McIndoe RA, et al. Early pathogenic events associated with Sjogren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab Invest 2006;86:1243-1260.
DOI
|
8 |
Robinson CP, Yamamoto H, Peck AB, Humphreys-Beher MG. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 1996;79:50-59.
DOI
|
9 |
Robinson CP, Yamachika S, Bounous DI, et al. A novel NOD-derived murine model of primary Sjogren's syndrome. Arthritis Rheum 1998;41:150-156.
DOI
|
10 |
Lam GY, Huang J, Brumell JH. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Semin Immunopathol 2010;32: 415-430.
DOI
|
11 |
Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014;24:R453-R462.
DOI
|
12 |
Mao X, Gu C, Chen D, Yu B, He J. Oxidative stress-induced diseases and tea polyphenols. Oncotarget 2017;8:81649-81661.
DOI
|
13 |
Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 2008;7:567-573.
DOI
|
14 |
Norheim KB, Jonsson G, Harboe E, Hanasand M, Goransson L, Omdal R. Oxidative stress, as measured by protein oxidation, is increased in primary Sjogren's syndrome. Free Radic Res 2012; 46:141-146.
DOI
|
15 |
Pagano G, Castello G, Pallardo FV. Sjogren's syndrome-associated oxidative stress and mitochondrial dysfunction: prospects for chemoprevention trials. Free Radic Res 2013;47:71-73.
DOI
|
16 |
Kurimoto C, Kawano S, Tsuji G, et al. Thioredoxin may exert a protective effect against tissue damage caused by oxidative stress in salivary glands of patients with Sjogren's syndrome. J Rheumatol 2007;34:2035-2043.
|
17 |
Wakamatsu TH, Dogru M, Matsumoto Y, et al. Evaluation of lipid oxidative stress status in Sjogren syndrome patients. Invest Ophthalmol Vis Sci 2013;54:201-210.
DOI
|
18 |
Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014;2014:360438.
DOI
|
19 |
Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558.
DOI
|
20 |
Ryo K, Yamada H, Nakagawa Y, et al. Possible involvement of oxidative stress in salivary gland of patients with Sjogren's syndrome. Pathobiology 2006;73:252-260.
DOI
|
21 |
Cejkova J, Ardan T, Simonova Z, et al. Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjogren's syndrome). Nitric Oxide 2007;17:10-17.
DOI
|
22 |
Jiang S, Hu L, Ping L, Sun F, Wang X. Glutathione protects against hepatic injury in a murine model of primary Sjogren's syndrome. Bosn J Basic Med Sci 2016;16:227-231.
DOI
|
23 |
Spiteller G. Linoleic acid peroxidation--the dominant lipid peroxidation process in low density lipoprotein--and its relationship to chronic diseases. Chem Phys Lipids 1998;95:105-162.
DOI
|
24 |
Yamauchi Y, Matsuno T, Omata K, Satoh T. Relationship between hyposalivation and oxidative stress in aging mice. J Clin Biochem Nutr 2017;61:40-46.
DOI
|
25 |
Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15:316-328.
DOI
|
26 |
McGrath LT, McGleenon BM, Brennan S, McColl D, McILroy S, Passmore AP. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 2001;94:485-490.
DOI
|
27 |
Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2002;251:69-76.
DOI
|
28 |
Frijhoff J, Winyard PG, Zarkovic N, et al. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 2015;23: 1144-1170.
DOI
|
29 |
Giera M, Lingeman H, Niessen WM. Recent advancements in the LC- and GC-based analysis of malondialdehyde (MDA): a brief overview. Chromatographia 2012;75:433-440.
DOI
|
30 |
Tsikas D. Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: analytical and biological challenges. Anal Biochem 2017;524:13-30.
DOI
|
31 |
Knight JA, Pieper RK, McClellan L. Specificity of the thiobarbituric acid reaction: its use in studies of lipid peroxidation. Clin Chem 1988;34:2433-2438.
DOI
|
32 |
Domijan AM, Ralic J, Radic Brkanac S, Rumora L, Zanic-Grubisic T. Quantification of malondialdehyde by HPLC-FL - application to various biological samples. Biomed Chromatogr 2015;29:41-46.
DOI
|
33 |
Khoubnasabjafari M, Ansarin K, Jouyban A. Reliability of malondialdehyde as a biomarker of oxidative stress in psychological disorders. Bioimpacts 2015;5:123-127.
DOI
|
34 |
Breusing N, Grune T, Andrisic L, et al. An inter-laboratory validation of methods of lipid peroxidation measurement in UVA-treated human plasma samples. Free Radic Res 2010;44:1203-1215.
DOI
|
35 |
Tsikas D, Rothmann S, Schneider JY, et al. Development, validation and biomedical applications of stable-isotope dilution GC-MS and GC-MS/MS techniques for circulating malondialdehyde (MDA) after pentafluorobenzyl bromide derivatization: MDA as a biomarker of oxidative stress and its relation to 15(S)-8-isoprostaglandin F2α and nitric oxide (NO). J Chromatogr B Analyt Technol Biomed Life Sci 2016;1019:95-111.
DOI
|
36 |
Mateos R, Lecumberri E, Ramos S, Goya L, Bravo L. Determination of malondialdehyde (MDA) by high-performance liquid chromatography in serum and liver as a biomarker for oxidative stress. Application to a rat model for hypercholesterolemia and evaluation of the effect of diets rich in phenolic antioxidants from fruits. J Chromatogr B Analyt Technol Biomed Life Sci 2005;827:76-82.
DOI
|